Caroline Smith‐Burchnell

1.8k citations
12 papers · 1.4k indexed · 1 hit paper · h-index 9
Topics
HIV Research and Treatment (6 papers)HIV/AIDS drug development and treatment (5 papers)Biochemical and Molecular Research (3 papers)

In The Last Decade

Caroline Smith‐Burchnell

12 papers receiving 1.3k citations

Hit Papers

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, an...20052026201220192005250500750

Peers

Caroline Smith‐Burchnell
Comparison fields: 5 of 84
  • Virology 947
  • Infectious Diseases 727
  • Molecular Biology 348
  • Immunology 337
  • Epidemiology 202
Replace Julie Mori with:
Julie Mori United Kingdom
Patrick Dorr United Kingdom
Hirotomo Nakata Japan
Malcolm Macartney United Kingdom
Amy M. Princiotto United States
Karl Salzwedel United States
John Delehanty United States
Barbara Maschera United Kingdom
Serena Xu United States
T.M. Jenkins United Kingdom
Caroline Smith‐Burchnell relative to Julie Mori United Kingdom Julie Mori's profile →
Citations per field
00.5×1.5×
Julie Mori · 1×
Citations per year

Countries citing papers authored by Caroline Smith‐Burchnell

Since Specialization
Citations

This map shows the geographic impact of Caroline Smith‐Burchnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Smith‐Burchnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Smith‐Burchnell more than expected).

Fields of papers citing papers by Caroline Smith‐Burchnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Smith‐Burchnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Smith‐Burchnell. The network helps show where Caroline Smith‐Burchnell may publish in the future.

Co-authorship network of co-authors of Caroline Smith‐Burchnell

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Smith‐Burchnell. A scholar is included among the top collaborators of Caroline Smith‐Burchnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Smith‐Burchnell. Caroline Smith‐Burchnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1
Pre-clinical evaluation of HIV replication inhibitors that target the HIV-integrase-LEDGF/p75 interaction
3
2 10
3 12
4 51
5 273
6
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activitybreakdown →
909
7 6
8 45
9 14
10 25
11 2
12 8

About Caroline Smith‐Burchnell

Caroline Smith‐Burchnell is a scholar working on Virology, Immunology and Infectious Diseases, having authored 12 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (5 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Virology (947 citations), Infectious Diseases (727 citations) and Immunology (337 citations). Caroline Smith‐Burchnell has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Mike Westby, Julie Mori, Manos Perros, Patrick Dorr, Anthony Wood, Duncan Armour, Paul Griffin, Blanda Stammen, Malcolm Macartney and Rob Webster. Their work appears in journals such as Journal of Virology, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026